Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. (linkinghub.elsevier.com)

Authors: Broderick JP … Grotta JC Journal: The Lancet Published: 2026-02-21 DOI: https://doi.org/10.1016/S0140-6736(26)00097-8